Tocqueville Asset Management L.P. Bellerophon Therapeutics, Inc. Transaction History

Tocqueville Asset Management L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$5.07 - $8.27 $58,812 - $95,932	-11,600 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$6.12 - $10.37 $105,876 - $179,401	-17,300 Reduced 59.86%	11,600 $77,000
Q3 2020 Nov 16, 2020	BUY	$9.27 - $13.79 $32,445 - $48,265	3,500 Added 13.78%	28,900 $294,000
Q2 2020 Aug 12, 2020	BUY	$9.43 - $20.28 $132,963 - $285,948	14,100 Added 124.78%	25,400 $319,000
Q1 2020 May 15, 2020	BUY	$3.39 - $18.0 $38,307 - $203,400	11,300 New	11,300 $124,000

44K

Ticker BLPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,545,450
Market Cap $573K
Description
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development...

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on Tocqueville Asset Management L.P. with notifications on news.